首页> 美国卫生研究院文献>Aging (Albany NY) >T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv
【2h】

T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv

机译:通过基于SunTag的抗CD3 / CD28 scFv的聚类刺激T细胞的增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Therapeutic T cell expansion is limited by low rates and poor functionality, especially for T cells from aged cancer patients. Here, we describe a novel method for T cell stimulation and expansion using a system named SunTag-based clustering of anti-CD3/CD28 scFv (SBCS). In this method, SunTag was used to recruit up to 13 copies of anti-CD3/CD28 scFv for T cell activation. Compared with the traditional method using immobilized CD3/CD28 antibodies, the SBCS system produced approximately 1.5-fold greater expansion of T cells from healthy donors, and more than 2-fold greater expansion of T cells from aged cancer patients after stimulation. The efficiency of expansion depended mainly on the concentration of the clustered polymers of anti-CD3 scFv rather than anti-CD28 scFv. We also demonstrated that the SBCS-expanded T cells could be used to prepare functional chimeric antigen receptor modified T cells for antitumor therapy.
机译:治疗性T细胞扩增受到速率低和功能差的限制,特别是对于老年癌症患者的T细胞。在这里,我们描述了一种新型的T细胞刺激和扩增方法,使用一种名为基于SunTag的抗CD3 / CD28 scFv(SBCS)聚类系统。在这种方法中,使用SunTag募集多达13个拷贝的抗CD3 / CD28 scFv用于T细胞活化。与使用固定化CD3 / CD28抗体的传统方法相比,SBCS系统在刺激后产生了健康供体的T细胞扩增约1.5倍,而老年癌症患者的T细胞则扩增了2倍以上。扩增效率主要取决于抗CD3 scFv的簇状聚合物的浓度,而不是抗CD28 scFv。我们还证明了SBCS扩增的T细胞可用于制备功能性嵌合抗原受体修饰的T细胞用于抗肿瘤治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号